| Literature DB >> 21518340 |
Clara D M Van Karnebeek1, Paula J Waters, Michael A Sargent, Michelle M Mezei, Michelle M Mezey, Lee-Jun Wong, Jing Wang, Sylvia Stöckler-Ipsiroglu.
Abstract
Diagnosis of mitochondrial disease is often a challenge because of the extreme heterogeneity of the clinical phenotype and the variety of underlying gene defects. Insight into the range of clinical phenotypes associated with a particular mitochondrial DNA mutation will facilitate better recognition of patients at risk by focused gene testing. We present a family affected by the mitochondrial m.13513G>A (p.D393N, ND5) mutation, illustrating a previously unreported degree of clinical heterogeneity, varying from mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) in a 10-year-old female, to a fatal neonatal course with metabolic acidosis and hypotonia in a younger sister, to absence of medical problems in the mother. The mutation loads ranging from 66% in the deceased neonate to 30% in the female with MELAS and 7% in the asymptomatic mother, correlated with severity of the clinical phenotype. The importance of proactive collection and storage of appropriate samples during the diagnostic work-up of an acutely ill or deceased neonate, allowing subsequent mitochondrial investigations, is hereby illustrated. © The Authors. Developmental Medicine & Child NeurologyEntities:
Mesh:
Substances:
Year: 2011 PMID: 21518340 DOI: 10.1111/j.1469-8749.2010.03907.x
Source DB: PubMed Journal: Dev Med Child Neurol ISSN: 0012-1622 Impact factor: 5.449